Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by go4futureon Feb 20, 2009 8:16am
457 Views
Post# 15792091

EMEA Raptiva Withdrawal Recommendation

EMEA Raptiva Withdrawal RecommendationThe Psoriasis drug Raptiva has been recommended for withrawal by the Europe's main medical regulator (EMEA), marketed in Europe by Merck Serono and in the USA by Genentech. Also FDA PML warning/review and potential US market withdrawl recomendation a likely outcome...

https://www.reuters.com/article/companyNews/idUSN1950951120090219
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities